Cell & Gene: The Podcast

In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg

4 snips
Sep 28, 2023
Guest
Andrew Scharenberg
Dr. Andrew Scharenberg, Umoja Biopharma's CEO, discusses the evolution of in vivo CAR-T cell therapeutics and the advantages of this technology. They also cover Umoja's lentiviral vector development and manufacturing facility, and their goals for the future.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 2min
2
Developing In Vivo CAR T Cell Therapies
01:40 • 12min
3
The Importance of Building a Manufacturing Facility in the Cell and Gene Therapy Industry
13:37 • 10min
4
Plans and Expectations for Umoja Biopharma in 2024
23:22 • 3min
5
Exploring the Intersection of AI and Whales
26:26 • 4min